RISK STRATIFICATION AND PATIENT COUNSELING FOR NATALIZUMAB IN MULTIPLE SCLEROSIS

被引：38
作者：
Fox, Robert J. [1 ]
Rudick, Richard A.
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44106 USA
来源：
NEUROLOGY | 2012年 / 78卷 / 06期
基金：
美国国家卫生研究院;
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
D O I：
10.1212/WNL.0b013e318245d2d0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [31] Clinical commentary on "Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab"
    Salmen, Anke
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 360 - 362
  • [32] Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis: A Postmortem Study
    Wuethrich, Christian
    Popescu, Bogdan F. Gh
    Gheuens, Sarah
    Marvi, Michael
    Ziman, Ronald
    Denq, Stephen Pojen
    Tham, Mylyne
    Norton, Elizabeth
    Parisi, Joseph E.
    Dang, Xin
    Lucchinetti, Claudia F.
    Koralnik, Igor J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (11) : 1043 - 1051
  • [33] An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
    Kornek, Barbara
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 675 - 684
  • [34] Use of natalizumab in multiple sclerosis: current perspectives
    Gandhi, Sirin
    Jakimovski, Dejan
    Ahmed, Rahil
    Hojnacki, David
    Kolb, Channa
    Weinstock-Guttman, Bianca
    Zivadinov, Robert
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (09) : 1151 - 1162
  • [35] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [36] Best practice in the use of natalizumab in multiple sclerosis
    Fernandez, Oscar
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (02) : 69 - 79
  • [37] Risk stratification of progressive multifocal leukoencephalopathy under natalizumab
    Warnke, C.
    Adams, O.
    Hartung, H. P.
    Gold, R.
    Hemmer, B.
    Hohlfeld, R.
    Stangel, M.
    Zipp, F.
    Wiendl, H.
    Kieseier, B. C.
    NERVENARZT, 2011, 82 (10): : 1314 - 1319
  • [38] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [39] Natalizumab treatment of multiple sclerosis: new insights
    Delbue, Serena
    Comar, Manola
    Ferrante, Pasquale
    IMMUNOTHERAPY, 2017, 9 (02) : 157 - 171
  • [40] JCV detection in multiple sclerosis patients treated with natalizumab
    Sadiq, Saud A.
    Puccio, Lauren M.
    Brydon, Edward W. A.
    JOURNAL OF NEUROLOGY, 2010, 257 (06) : 954 - 958
12345